Literature DB >> 9551280

Do certain countries produce only positive results? A systematic review of controlled trials.

A Vickers1, N Goyal, R Harland, R Rees.   

Abstract

OBJECTIVE: To determine whether clinical trials originating in certain countries always have positive results. DATA SOURCES: Abstracts of trials from Medline (January 1966-June 1995). STUDY SELECTION: Two separate studies were conducted. The first included trials in which the clinical outcome of a group of subjects receiving acupuncture was compared to that of a group receiving placebo, no treatment, or a nonacupuncture intervention. In the second study, randomized or controlled trials of interventions other than acupuncture that were published in China, Japan, Russia/USSR, or Taiwan were compared to those published in England. DATA EXTRACTION: Blinded reviewers determined inclusion and outcome and separately classified each trial by country of origin. DATA SYNTHESIS: In the study of acupuncture trials, 252 of 1085 abstracts met the inclusion criteria. Research conducted in certain countries was uniformly favorable to acupuncture; all trials originating in China, Japan, Hong Kong, and Taiwan were positive, as were 10 out of 11 of those published in Russia/USSR. In studies that examined interventions other than acupuncture, 405 of 1100 abstracts met the inclusion criteria. Of trials published in England, 75% gave the test treatment as superior to control. The results for China, Japan, Russia/USSR, and Taiwan were 99%, 89%, 97%, and 95%, respectively. No trial published in China or Russia/USSR found a test treatment to be ineffective.
CONCLUSIONS: Some countries publish unusually high proportions of positive results. Publication bias is a possible explanation. Researchers undertaking systematic reviews should consider carefully how to manage data from these countries.

Mesh:

Year:  1998        PMID: 9551280     DOI: 10.1016/s0197-2456(97)00150-5

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  166 in total

1.  Review of randomised controlled trials of traditional Chinese medicine.

Authors:  J L Tang; S Y Zhan; E Ernst
Journal:  BMJ       Date:  1999-07-17

2.  Is there epidemiology in Russia?

Authors:  V Vlassov
Journal:  J Epidemiol Community Health       Date:  2000-10       Impact factor: 3.710

Review 3.  Chinese medicinal herbs for chronic hepatitis B.

Authors:  J P Liu; H McIntosh; H Lin
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 4.  Topiramate versus carbamazepine for the treatment of classical trigeminal neuralgia: a meta-analysis.

Authors:  Qiang-Ping Wang; Min Bai
Journal:  CNS Drugs       Date:  2011-10-01       Impact factor: 5.749

Review 5.  Laser acupuncture: past, present, and future.

Authors:  Peter Whittaker
Journal:  Lasers Med Sci       Date:  2004       Impact factor: 3.161

Review 6.  Acupuncture for children with autism spectrum disorders: a systematic review of randomized clinical trials.

Authors:  Myeong Soo Lee; Tae-Young Choi; Byung-Cheul Shin; Edzard Ernst
Journal:  J Autism Dev Disord       Date:  2012-08

Review 7.  Traditional Chinese medicine for pressure ulcer: a meta-analysis.

Authors:  Qin-Hong Zhang; Zhong-Ren Sun; Jin-Huan Yue; Xue Ren; Li-Bo Qiu; Xiao-Lin Lv; Wei Du
Journal:  Int Wound J       Date:  2012-04-18       Impact factor: 3.315

Review 8.  Moxibustion for the treatment of osteoarthritis: a systematic review and meta-analysis.

Authors:  Tae-Young Choi; Jiae Choi; Kun Hyung Kim; Myeong Soo Lee
Journal:  Rheumatol Int       Date:  2012-03-30       Impact factor: 2.631

Review 9.  Acupuncture for Bell's palsy: a systematic review and meta-analysis.

Authors:  Jong-In Kim; Myeong Soo Lee; Tae-Young Choi; Hyangsook Lee; Hyo-Jung Kwon
Journal:  Chin J Integr Med       Date:  2011-10-12       Impact factor: 1.978

Review 10.  Auriculotherapy for pain management: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Gary N Asher; Daniel E Jonas; Remy R Coeytaux; Aimee C Reilly; Yen L Loh; Alison A Motsinger-Reif; Stacey J Winham
Journal:  J Altern Complement Med       Date:  2010-10       Impact factor: 2.579

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.